Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that it has amended and restated its investor agreement with Sanofi SA (ADR) (NYSE:SNY), which was originally entered into in December 2007. Sanofi SA (ADR) (NYSE:SNY) stock opened at $50.53 in last trading session, and closed at $50.81, trading in the range of $50.37 – $50.81. The stock showed a positive/negative weekly performance of -2.36%.
GlaxoSmithKline plc (ADR) (NYSE:GSK)’s shares rose Thursday after it said it had received approval from the US Food and Drug Administration for the combined use of Mekinist, also known as trametinib, and Tafinlar, also known as dabrafenib, for the treatment of melanoma that cannot be removed by surgery or that has spread to other parts of the body. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares closed at $52.75 on last trade day, by decreasing -0.17%. Stock 52 week range is $43.68 – $54.00. Company’s market capitalization is $129.47 billion.
Jefferies Group upgraded shares of Johnson & Johnson (NYSE:JNJ) from a hold rating to a buy rating in a research report released on Thursday morning, TheFlyOnTheWall.com reports. Jefferies Group currently has $108.00 price objective on the stock, up from their previous price objective of $102.00. Johnson & Johnson (NYSE:JNJ) stock climbed 0.01% and finished the last session at $94.74. The EPS of the stock remained 4.48. Company’s market capitalization is $267.30 billion.
Bristol-Myers Squibb Co (NYSE:BMY) announces the FDA approved Farxiga, a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Farxiga should not be used for the treatment of patients with type 1 diabetes or diabetic ketoacidosis. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $55.82 in last trading session and closed at $56.18. The 52 week range of the stock is $33.95 – $56.28 and the day range was $55.42 – $56.28.
Abbott Laboratories (NYSE:ABT) had its price target upped by Barclays from $38.00 to $40.00 in a research note issued to investors on Thursday, Analyst Ratings.Net reports. The firm currently has an equal weight rating on the stock. Abbott Laboratories (NYSE:ABT) shares closed at $39.27 on last trade day, by climbing 0.76%. Stock 52 week range is $32.55 – $39.69. Company’s market capitalization is $61.18 billion.